US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 2.8000
  • -0.1600-5.41%
Close Nov 21 16:00 ET
4.22MMarket Cap-667P/E (TTM)

Galmed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.13%-1.06M
25.60%-1.02M
-7.96%-1.83M
66.83%-6.14M
77.68%-898K
30.09%-2.18M
76.87%-1.37M
68.91%-1.7M
43.75%-18.5M
42.43%-4.02M
Net income from continuing operations
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Operating gains losses
-106.10%-5K
115.79%9K
-103.13%-1K
-97.51%13K
-105.75%-44K
118.51%82K
-201.79%-57K
-77.93%32K
1,513.51%523K
15,400.00%765K
Depreciation and amortization
--0
722.22%74K
12.50%9K
-11.43%31K
-33.33%6K
0.00%8K
0.00%9K
-11.11%8K
-16.67%35K
-10.00%9K
Other non cash items
1,700.00%54K
-108.23%-13K
97.73%-4K
-30.56%-47K
93.13%-32K
-99.36%3K
593.75%158K
-1,660.00%-176K
-376.92%-36K
-7,866.67%-466K
Change In working capital
165.14%669K
-145.54%-92K
-1,894.44%-718K
105.39%132K
154.68%993K
-152.24%-1.03M
107.59%202K
-161.02%-36K
-0.04%-2.45M
-2,489.47%-1.82M
-Change in receivables
32.17%-291K
-47.58%119K
-12.06%226K
15.00%345K
-11.04%290K
20.11%-429K
-0.87%227K
-8.87%257K
195.85%300K
-40.62%326K
-Change in payables and accrued expense
260.54%960K
-744.00%-211K
-222.18%-944K
92.26%-213K
132.82%703K
-123.89%-598K
99.13%-25K
-31.39%-293K
-28.73%-2.75M
-352.85%-2.14M
Cash from discontinued investing activities
Operating cash flow
51.13%-1.06M
25.60%-1.02M
-7.96%-1.83M
66.83%-6.14M
77.68%-898K
30.09%-2.18M
76.87%-1.37M
68.91%-1.7M
43.75%-18.5M
42.43%-4.02M
Investing cash flow
Cash flow from continuing investing activities
117.37%614K
97.45%1.39M
-68.02%432K
-95.44%800K
15.16%2.28M
-168.98%-3.54M
-83.01%705K
-78.59%1.35M
53.23%17.56M
-69.01%1.98M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
63.64%-4K
0.00%-1K
Net business purchase and sale
--0
----
----
---1.5M
--0
--0
----
----
--0
--0
Net investment purchase and sale
117.37%614K
-36.87%1.39M
-68.02%432K
-86.91%2.3M
15.10%2.28M
-168.98%-3.54M
-46.91%2.21M
-78.59%1.35M
53.10%17.57M
134.85%1.98M
Cash from discontinued investing activities
Investing cash flow
117.37%614K
97.45%1.39M
-68.02%432K
-95.44%800K
15.16%2.28M
-168.98%-3.54M
-83.01%705K
-78.59%1.35M
53.23%17.56M
-69.01%1.98M
Financing cash flow
Cash flow from continuing financing activities
8,735.71%6.19M
0
-99.60%70K
0
Net common stock issuance
----
----
----
8,735.71%6.19M
--0
----
----
----
-99.60%70K
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued financing activities
Financing cash flow
----
----
----
8,735.71%6.19M
--0
----
----
----
-99.60%70K
--0
Net cash flow
Beginning cash position
73.93%1.96M
-11.53%1.58M
39.81%2.98M
-28.95%2.13M
-61.75%1.6M
-46.32%1.12M
-53.67%1.79M
-28.95%2.13M
-57.54%3M
15.88%4.18M
Current changes in cash
1,567.65%7.89M
156.65%375K
-306.40%-1.4M
197.70%848K
167.53%1.38M
-77.27%473K
62.41%-662K
-140.14%-344K
78.63%-868K
-238.02%-2.05M
End cash Position
516.34%9.84M
73.93%1.96M
-11.53%1.58M
39.81%2.98M
39.81%2.98M
-61.75%1.6M
-46.32%1.12M
-53.67%1.79M
-28.95%2.13M
-28.95%2.13M
Free cash flow
51.13%-1.06M
25.60%-1.02M
-7.96%-1.83M
66.84%-6.14M
77.69%-898K
30.09%-2.18M
76.89%-1.37M
68.91%-1.7M
43.76%-18.51M
42.43%-4.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.13%-1.06M25.60%-1.02M-7.96%-1.83M66.83%-6.14M77.68%-898K30.09%-2.18M76.87%-1.37M68.91%-1.7M43.75%-18.5M42.43%-4.02M
Net income from continuing operations -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Operating gains losses -106.10%-5K115.79%9K-103.13%-1K-97.51%13K-105.75%-44K118.51%82K-201.79%-57K-77.93%32K1,513.51%523K15,400.00%765K
Depreciation and amortization --0722.22%74K12.50%9K-11.43%31K-33.33%6K0.00%8K0.00%9K-11.11%8K-16.67%35K-10.00%9K
Other non cash items 1,700.00%54K-108.23%-13K97.73%-4K-30.56%-47K93.13%-32K-99.36%3K593.75%158K-1,660.00%-176K-376.92%-36K-7,866.67%-466K
Change In working capital 165.14%669K-145.54%-92K-1,894.44%-718K105.39%132K154.68%993K-152.24%-1.03M107.59%202K-161.02%-36K-0.04%-2.45M-2,489.47%-1.82M
-Change in receivables 32.17%-291K-47.58%119K-12.06%226K15.00%345K-11.04%290K20.11%-429K-0.87%227K-8.87%257K195.85%300K-40.62%326K
-Change in payables and accrued expense 260.54%960K-744.00%-211K-222.18%-944K92.26%-213K132.82%703K-123.89%-598K99.13%-25K-31.39%-293K-28.73%-2.75M-352.85%-2.14M
Cash from discontinued investing activities
Operating cash flow 51.13%-1.06M25.60%-1.02M-7.96%-1.83M66.83%-6.14M77.68%-898K30.09%-2.18M76.87%-1.37M68.91%-1.7M43.75%-18.5M42.43%-4.02M
Investing cash flow
Cash flow from continuing investing activities 117.37%614K97.45%1.39M-68.02%432K-95.44%800K15.16%2.28M-168.98%-3.54M-83.01%705K-78.59%1.35M53.23%17.56M-69.01%1.98M
Net PPE purchase and sale --------------0----------------63.64%-4K0.00%-1K
Net business purchase and sale --0-----------1.5M--0--0----------0--0
Net investment purchase and sale 117.37%614K-36.87%1.39M-68.02%432K-86.91%2.3M15.10%2.28M-168.98%-3.54M-46.91%2.21M-78.59%1.35M53.10%17.57M134.85%1.98M
Cash from discontinued investing activities
Investing cash flow 117.37%614K97.45%1.39M-68.02%432K-95.44%800K15.16%2.28M-168.98%-3.54M-83.01%705K-78.59%1.35M53.23%17.56M-69.01%1.98M
Financing cash flow
Cash flow from continuing financing activities 8,735.71%6.19M0-99.60%70K0
Net common stock issuance ------------8,735.71%6.19M--0-------------99.60%70K--0
Proceeds from stock option exercised by employees --------------0------------------0----
Cash from discontinued financing activities
Financing cash flow ------------8,735.71%6.19M--0-------------99.60%70K--0
Net cash flow
Beginning cash position 73.93%1.96M-11.53%1.58M39.81%2.98M-28.95%2.13M-61.75%1.6M-46.32%1.12M-53.67%1.79M-28.95%2.13M-57.54%3M15.88%4.18M
Current changes in cash 1,567.65%7.89M156.65%375K-306.40%-1.4M197.70%848K167.53%1.38M-77.27%473K62.41%-662K-140.14%-344K78.63%-868K-238.02%-2.05M
End cash Position 516.34%9.84M73.93%1.96M-11.53%1.58M39.81%2.98M39.81%2.98M-61.75%1.6M-46.32%1.12M-53.67%1.79M-28.95%2.13M-28.95%2.13M
Free cash flow 51.13%-1.06M25.60%-1.02M-7.96%-1.83M66.84%-6.14M77.69%-898K30.09%-2.18M76.89%-1.37M68.91%-1.7M43.76%-18.51M42.43%-4.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data